text.skipToContent text.skipToNavigation
Need help? Please contact us
You searched for "x-vivo"
Too many choices? Use the filter option on the left to narrow your product listing.
1-10 of 159 results
11-20 of 763 results
  • Instructions for Use – TheraPEAK® T-VIVO® Cell Culture Medium for Gamma Delta (γδ) T Cells
    Instructions for how to culture gamma delta (γδ) T Cells using TheraPEAK® T-VIVO® Cell Culture Medium
  • Developing Patient-specific Cell Therapy Manufacturing Processes
    Poster presentation about patient-specific cellular therapies and their tremendous potential for being able to treat life threatening diseases where there are currently no cures.
  • Modeling a 3D respiratory model with the Quasi Vivo® QV600 Fluidic Cell Culture System
    In this Technical Note, we provide detailed information of how the Quasi Vivo® QV600 System was set up for the ALI culture of normal human bronchial or small airway epithelial (NHBE, SAE) cells.
  • Non-Viral Methods for Ex vivo Cell and Gene Therapy – Is the Future Non-viral?
    Learn from this interview about the types and benefits of non-viral methods for ex vivo cell and gene therapy as well as the readiness of electroporation-based technologies for use in GMP manufacturing.
  • NK Cell Assay using 3D Bioprinted Tumor Models
    This white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
  • A Novel Chemically Defined Medium Supports Superior Cross-platform T-cell Expansion
    This poster showcases how the chemically defined TheraPEAK® T-VIVO® Medium supports superior T-cell expansion across different platforms.
  • A Novel In Vitro Liver Cell Culture Flow System Allowing Long-Term Metabolism and Hepatotoxicity Studies]
    Manuscript published in Applied In Vitro Toxicology journal describes improvement of CYP450 phenotype of primary cryopreserved hepatocytes using Quasi Vivo® System
  • A Non-Viral Method for Modifying and Expanding Primary T Cells
    Learn how Lonza’s Cocoon® Platform, 4D-Nucleofector® LV Unit and X-VIVO® 15 Medium are integrated to enable non-viral genetic modification and subsequent expansion of primary T cells in a functionally-closed, automated workflow.
  • Clonetics™ and Poietics™ Disease Cells
    In Vivo Relevance. In Vitro Results. Product listings on Poster Six disease cell lines are identified:Airway, Skeletal Muscle,Adipose, Cardiac, Renal and Dermal
  • Fast-Track Development of an In Vitro 3D Lung/Immune Cell Model Using the Quasi Vivo® System
    Watch Video